YP05002, developed by Yao Pharma, is in Phase 1 clinical development in Australia and can potentially help with metabolic diseases; Yao Pharma will receive an upfront payment of $150m for a worldwide licence.

The structure of the bonds allows Chinese corporates to raise funds in multiple currencies with an onshore issuance. The Yulan bond market is still small.

Prudential Financial is selling its 13% stake in the Hong Kong-headquartered reinsurer, which is majority owned by Chinese conglomerate Fosun.

A new loan for the Chinese conglomerate included a greenshoe option and involved Chinese and international banks.

The rationale behind all the winners for the best finance houses across Asia Pacific.

Hong Kong-based Yang has previous CFO experience at major Chinese e-commerce firms, and has also worked in the technology, media and telecommunications' investment banking team at Citi.

Xin Fang joins DLA Piper from Mayer Brown, where she was counsel.

CEO Hahn notes hardening prices in both property and casualty businesses and says retained profits must improve before company, majority owned by Fosun group, considers an IPO.

With a quick M&A deal, the world’s second-largest brewer cements position in the Asia Pacific by scaling up presence in the beer and cider market down under.

A strategic divestment and one of the first non-property high-yield Chinese bond sales to come to market since the Covid-19 lockdown secure the Chinese conglomerate’s war chest.